![Brain slices under a microscope.](https://unclineberger.org/wp-content/uploads/sites/867/2023/01/Hingtgen-brain-slice-feature-600x400.jpg)
January 25, 2023
Devising a smarter way to treat brain tumors
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
January 25, 2023
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
September 26, 2022
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
February 24, 2022
Greg Wang, PhD, and colleagues have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.
January 31, 2022
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
January 26, 2022
In a laboratory study, UNC Lineberger researchers report a novel combination of two drugs delivered in a nanoparticle formulation may suggest an approach for a less toxic treatment for medulloblastoma, the most common pediatric brain cancer.
January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.
November 11, 2020
Greg Wang, PhD, and colleagues have identified an evolutionarily conserved pathway responsible for “closing down” gene activity in the mammalian cell.
September 16, 2020
Qi Zhang, PhD, Robert McGinty, MD, PhD, and team determined the high-resolution structure of a key DNA-sensing protein in the innate immune system called cGAS while it is bound to the nucleosome.
March 23, 2020
The $125,000 award will support the Liu lab in investigating a specific therapeutic target in basal-like breast cancer, an aggressive breast cancer type.